113 related articles for article (PubMed ID: 6818483)
21. A kidney biopsy is clearly mandatory to confirm the indication of plasma exchanges in adult haemolytic uraemic syndrome.
Pourrat O; Touchard G; Robert R; Badia P; Bauwens M; Hauet T; Patte D
Ann Med Interne (Paris); 1994; 145(5):369-72. PubMed ID: 7985952
[TBL] [Abstract][Full Text] [Related]
22. [Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z
Gan To Kagaku Ryoho; 1983 Mar; 10(3):834-9. PubMed ID: 6882001
[TBL] [Abstract][Full Text] [Related]
23. [Three cases of drug-induced hemolytic uremic syndrome].
Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
Hartmann JT; Kanz L; Bokemeyer C
Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418
[TBL] [Abstract][Full Text] [Related]
25. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
[TBL] [Abstract][Full Text] [Related]
26. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
[TBL] [Abstract][Full Text] [Related]
27. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Sheldon R; Slaughter D
Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
[TBL] [Abstract][Full Text] [Related]
28. [Fluorouracil, mitomycin-C and adriamycin in the treatment of metastasizing gastrointestinal adenocarcinomas].
Späti B; Jungi WF; Mayr AC; Hammer B; Senn HJ
Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1076-8. PubMed ID: 7423154
[TBL] [Abstract][Full Text] [Related]
29. [2 cases of aplastic anemia and renal disorders due to mitomycin C].
Tomura T; Takizawa Y; Irikae K; Korenaga O; Higo O
Gan No Rinsho; 1966 Mar; 12(3):173-6. PubMed ID: 6010939
[No Abstract] [Full Text] [Related]
30. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
Giroux L; Bettez P; Giroux L
Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.
Bijol V; Mendez GP; Hurwitz S; Rennke HG; Nosé V
Am J Surg Pathol; 2006 May; 30(5):575-84. PubMed ID: 16699311
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
McCarthy JT; Staats BA
Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
[TBL] [Abstract][Full Text] [Related]
34. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
[TBL] [Abstract][Full Text] [Related]
35. [Two cases of carcinoid tumor of the stomach which responded to oral administration of UFT].
Yoshimori M; Okazaki N; Yoshida S; Tajiri H; Yamaguchi H; Hirota T
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1856-62. PubMed ID: 6820885
[TBL] [Abstract][Full Text] [Related]
36. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
38. [Mitomycin-induced hemolytic-uremic syndrome].
Zeller G; Wandel E; Schwarting A
Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1399-402. PubMed ID: 12813674
[TBL] [Abstract][Full Text] [Related]
39. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
